Cargando…

Long-term safety of rituximab induced peripheral B-cell depletion in autoimmune neurological diseases

BACKGROUND: B-cells play a pivotal role in several autoimmune diseases, including patients with immune-mediated neurological disorders (PIMND), such as neuromyelitis optica (NMO), multiple sclerosis (MS), and myasthenia gravis (MG). Targeting B-cells has been an effective approach in ameliorating bo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Memon, Anza B., Javed, Adil, Caon, Christina, Srivastawa, Shitiz, Bao, Fen, Bernitsas, Evanthia, Chorostecki, Jessica, Tselis, Alexandros, Seraji-Bozorgzad, Navid, Khan, Omar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757948/ https://www.ncbi.nlm.nih.gov/pubmed/29309416 http://dx.doi.org/10.1371/journal.pone.0190425

Ejemplares similares

Cerebrospinal fluid humoral immunity in the differential diagnosis of multiple sclerosis
por: Bernitsas, Evanthia, et al.
Publicado: (2017)

Characterizing Fatigue-Related White Matter Changes in MS: A Proton Magnetic Resonance Spectroscopy Study
por: Yarraguntla, Kalyan, et al.
Publicado: (2019)

Structural and Neuronal Integrity Measures of Fatigue Severity in Multiple Sclerosis
por: Bernitsas, Evanthia, et al.
Publicado: (2017)

The Relationship Between Brain MR Spectroscopy and Disability in Multiple Sclerosis: 20‐Year Data from the U.S. Glatiramer Acetate Extension Study
por: Khan, Omar, et al.
Publicado: (2016)

Overlapping Autoimmune Neurological Syndrome: A Case Report of Triple-Positive Antibody
por: Bonner, Kyle, et al.
Publicado: (2022)

Effect of Obesity on Retinal Integrity in African Americans and Caucasian Americans With Relapsing Multiple Sclerosis
por: Rube, Jacob, et al.
Publicado: (2021)

Rituximab depletion of intrahepatic B cells to control refractory hepatic autoimmune overlap syndrome
por: Appanna, G D, et al.
Publicado: (2019)

Is Rituximab-Associated Hypogammaglobulinemia Always Linked to B-Cell Depletion?
por: Damianaki, Anthie, et al.
Publicado: (2022)

Pathophysiology and Imaging Diagnosis of Demyelinating Disorders
por: Bernitsas, Evanthia
Publicado: (2018)

The Emerging Role of Scalogram-Based Convolutional Neural Network in the Diagnosis of Epileptic Seizures
por: Bernitsas, Evanthia
Publicado: (2021)

COVID-19 in multiple sclerosis patients and risk factors for severe infection
por: Chaudhry, Farhan, et al.
Publicado: (2020)

Guillain Barré Syndrome and its variants as a manifestation of COVID-19: A systematic review of case reports and case series
por: Sriwastava, Shitiz, et al.
Publicado: (2021)

From Postural Orthostatic Tachycardia Syndrome to Radiologically Isolated Syndrome
por: Tripathi, Richa, et al.
Publicado: (2018)

Rituximab: B cell depletion: case report
Publicado: (2021)

Relevance of Medullary Vein Sign in Neurosarcoidosis
por: Liberio, Richard, et al.
Publicado: (2022)

Rituximab for Autoimmune Encephalitis with Epilepsy
por: Kurukumbi, Mohankumar, et al.
Publicado: (2020)

From Animal Models to Clinical Trials: The Potential of Antimicrobials in Multiple Sclerosis Treatment
por: Raghib, Muhammad Faraz, et al.
Publicado: (2023)

Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab
por: Nytrova, Petra, et al.
Publicado: (2023)

Population Pharmacodynamic Modelling of the CD19+ Suppression Effects of Rituximab in Paediatric Patients with Neurological and Autoimmune Diseases
por: Riva, Natalia, et al.
Publicado: (2023)

Repeated B-cell depletion with rituximab in rheumatoid arthritis
por: Edwards, J, et al.
Publicado: (2003)

B Cell Depletion: Rituximab in Glomerular Disease and Transplantation
por: Marinaki, S., et al.
Publicado: (2013)

Approved and Emerging Disease Modifying Therapies on Neurodegeneration in Multiple Sclerosis
por: Bross, Madeline, et al.
Publicado: (2020)

Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease
por: Tieu, Joanna, et al.
Publicado: (2021)

Effective treatment of CLIPPERS with long-term use of rituximab
por: Cipriani, Veronica P., et al.
Publicado: (2018)

Could Sars-Cov2 affect MS progression?
por: Di Stadio, Arianna, et al.
Publicado: (2020)

Imaging of the Spinal Cord in Multiple Sclerosis: Past, Present, Future
por: Chen, Yongsheng, et al.
Publicado: (2020)

Cold autoimmune hemolytic anemia resolved by rituximab
por: Palombi, Massimiliano, et al.
Publicado: (2010)

A Case of Autoimmune Hepatitis Treated with Rituximab
por: Barth, E., et al.
Publicado: (2010)

Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin
por: Ahmed, A. Razzaque, et al.
Publicado: (2018)

Efficacy of rituximab in non-paraneoplastic autoimmune retinopathy
por: Boudreault, Katherine, et al.
Publicado: (2017)

Treatment of Refractory Pediatric Autoimmune Hepatitis With Rituximab
por: Saul, Samantha A., et al.
Publicado: (2021)

Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry
por: Salmon, J H, et al.
Publicado: (2015)

Rituximab Monotherapy versus Rituximab and Bortezomib Combination Therapy for Treatment of Non-paraneoplastic Autoimmune Retinopathy
por: Maleki, Arash, et al.
Publicado: (2022)

Optical Coherence Tomography in Chronic Relapsing Inflammatory Optic Neuropathy, Neuromyelitis Optica and Multiple Sclerosis: A Comparative Study
por: Eslami, Maziar, et al.
Publicado: (2022)

B cell depletion in autoimmune disease
por: Gorman, Claire, et al.
Publicado: (2003)

Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases
por: Khojah, Amer M., et al.
Publicado: (2019)

Rituximab Use in Warm and Cold Autoimmune Hemolytic Anemia
por: Murakhovskaya, Irina
Publicado: (2020)

Rituximab rescue therapy for autoimmune pulmonary alveolar proteinosis
por: Bird, Daniel, et al.
Publicado: (2022)

B-Lymphocyte Depletion With Rituximab and β-Cell Function: Two-Year Results
por: Pescovitz, Mark D., et al.
Publicado: (2014)

Rapid depletion of B lymphocytes by ultra-low-dose rituximab delivered intrathecally
por: Svenningsson, Anders, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ouermi1rc65f6n5389kgps0oo2